New Insights Into Cardiovascular Disease in Cancer Survivors

Dear Colleagues,

The global population of cancer survivors is on the rise due to factors such as an aging demographic, improved early cancer detection, and recent advancements in cancer treatments. Although cancer-related mortality has seen a decrease, there has been a substantial increase in cardiovascular mortality among these survivors, constituting about a tenth of the survivor population. Gaining a deeper understanding of the underlying mechanisms and risk factors associated with CVD in this population is crucial for effective prevention, early detection, and management.

The Special Issue encompasses a range of topics related to CVD in cancer survivors, including the cardiotoxic effects of chemotherapy, radiotherapy, persistent endothelial dysfunction, biological mechanisms like inflammation and oxidative stress, shared lifestyle risk factors that are relevant to both cancer and cardiovascular disease, and personalized medicine approaches, including genetic testing, imaging techniques, and biomarker profiling, to identify high-risk individuals and tailor interventions accordingly.

This Special Issue aims to feature original articles as well as review articles that provide an in-depth understanding of the underlying mechanisms and risk factors associated with CVD in this population, which is critical for effective prevention, early detection, and management.

Dr. Kyae Hyung Kim
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiovascular disease
• cancer survivors
• underlying mechanisms
• risk factors associated with CVD
• personalized medicine approaches